CIO Bulletin Announces Valor Compounding Pharmacy as One of 2021 Most Trusted Companies
This press release features multimedia. See the full version here: https://www.businesswire.com/news/home/20211208005132/en/
Rick Niemi, Founder and CEO of Valor Compounding Pharmacy (Photo: Business Wire)
“CIO Bulletin 2021’s 10 Most Trusted Companies is a leading recognition program that identifies companies that have not only the most robust and reliable business and technology solutions, but also the most loyal customer base, â said JP Pande, editor-in-chief of CIO Bulletin magazine. The publication selected Valor based on its brand’s reputation in the US market, its commitment to quality and innovation within its industry, and its ability to establish a trusted online presence that offers convenience. and an exceptional customer experience.
“We are honored to be recognized by the CIO Bulletin as one of their 2021 Most Trusted Companies â, noted Rick Niemi, Founder and CEO of Valor. “Trust is a core virtue of Valor and a critical quality that we believe is required for any healthy relationship. With it, what we can accomplish is endless. Without it, no good thing will realize its full potential. “
Valor continues its ascent towards realizing its potential, having made Inc’s Fastest Growing List of Companies. 5000 two consecutive years, while having another record year of growth in 2022. Valor’s focus on improving the customer and user experience sets them apart from the competition and is one of the main reasons they are the partner of choice for so many all over the United States.
About Valor Compounding Pharmacy
Valor Compounding Pharmacy â¢, Inc. is a 503A multi-state licensed facility housing both sterile and non-sterile laboratories located in Berkeley, California. PCAB accredited and LegitScript Certified, Valor is a specialty pharmacy that manufactures medications tailored to meet the unique needs of each patient. Our goal is to reinvent and improve the provider and patient experience for compounding pharmacy, moving from a responsive provider to a proactive partner in patient healthcare. We do this by optimizing turnaround times, being data-driven, while reducing patient anxiety. We focus on non-sterile and sterile, hazardous and non-hazardous compound drugs, and we work with a network of providers, patients, healthcare systems / institutions, and researchers in a myriad of states across the United States.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20211208005132/en/
Valor Compounding Pharmacy
Founder & CEO